Masuda S, Fukuma H, Beppu Y
Eur J Cancer Clin Oncol. 1983 Nov;19(11):1521-8. doi: 10.1016/0277-5379(83)90081-0.
We studied the effect of human leukocyte interferon (HuIFN-alpha) on a human osteosarcoma (OS-OH) transplanted and passed serially in athymic mice. The growth of OS-OH was strikingly inhibited by HuIFN-alpha (50,000 IU/mouse), regardless of whether the interferon treatment was initiated 24 hr after tumor inoculation or 2 weeks later, when tumors had grown to an appreciable size (4-6 mm). The antitumor effect of HuIFN-alpha was found to be dose-dependent and a daily administration of HuIFN-alpha (50,000 IU/mouse) all but completely arrested the tumor growth.
我们研究了人白细胞干扰素(HuIFN-α)对在无胸腺小鼠体内连续传代移植的人骨肉瘤(OS-OH)的作用。无论在肿瘤接种后24小时还是2周后(此时肿瘤已生长到可观大小,4 - 6毫米)开始干扰素治疗,HuIFN-α(50,000国际单位/小鼠)均能显著抑制OS-OH的生长。发现HuIFN-α的抗肿瘤作用具有剂量依赖性,每天给予HuIFN-α(50,000国际单位/小鼠)几乎完全抑制了肿瘤生长。